Meeting
2023 ASCO Annual Meeting
Hospital Anxiety and Depression Scale (HADS) score trends among testicular cancer survivors: A longitudinal study.
Authors
Khalid Y. Alkhatib
University of Pennsylvania, Philadelphia, PA
Khalid Y. Alkhatib , Daniel Roberson , Ruchika Talwar , Hanna Jia , Katherine Nathanson , S. Bruce Malkowicz , Thomas J. Guzzo , Phillip Pierorazio , Linda A. Jacobs , David J. Vaughn
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Germ Cell/Testicular Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 5042)
DOI
10.1200/JCO.2023.41.16_suppl.5042
Abstract #
5042
Poster Bd #
136
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Impact of chemotherapy on anxiety, depression, and suicidality amongst testicular cancer survivors.
First Author: Tyler J. Nelson
Poster
2019 Supportive Care in Oncology Symposium
Unintended consequences of screening for anxiety and depression among survivors of pediatric, adolescent, and young adult (P-AYA) cancer.
First Author: Linda A. Jacobs
Poster
2017 Cancer Survivorship Symposium
Unmet need, survivorship concerns, and psychosocial outcomes among testicular cancer (TC) survivors.
First Author: Steven C Palmer
Poster
2017 Cancer Survivorship Symposium
Biopsychosocial distress assessment among testicular cancer survivors (TCS) using electronic patient reported outcomes (PROs).
First Author: Elizabeth A. Guancial